Emerging economies and novel technologies such as paper-based microfluidics are likely to provide high growth opportunities for the players operating in the microfluidic immunoassay market. High growth in emerging economies is attributed to rising aging population, presence of large pool of patient suffering from non-communicable and infectious diseases, increase in the influx of R&Dfunding, rising demand for quality healthcare, growing disposable income, and improving healthcare infrastructure. On the other hand, selection of suitable substrate material for designing microfluidic chip; reimbursement issues; difficulty in up-scaling the process for mass production; and designing low cost products for developing countries – are the major challenges for the market.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5034
The overall microfluidic immunoassay market is segmented by product (lab-on-chip/microfluidic diagnostics and other quantifiable POC diagnostics); technology (LOC POC technology and quantitative non-LOC POC technologies); application (cardiac biomarker detection, inflammatory biomarker detection, and others (diabetes, tumor, and hormones); and geography.
On the basis of technology, microfluidic immunoassay market is segmented into POC lab-on-chip (LOC) technologies and non-LOC POC technologies. Non-LOC POC technologies segment is estimated to command the largest share of the overall microfluidic immunoassay market in 2019. The large share of this segment is attributed to a greater adoption of these technologies – over the years – for wide range of diagnostic applications. Further, POC lab-on-chip (LOC) technologies market is categorized into electrochemical detection and optical detection. Electrochemical detection market commanded the largest share of the LOC POC technology market. This is due to the fact that Abbottss i-STAT microfluidic platform has dominance in the present market, and it is based on electrochemical detection technology.
Based on application, the cardiac biomarker detection segment is estimated to hold the largest share of the overall microfluidic immunoassay market in 2019. The large share of the cardiac biomarker detection segment is attributed to high prevalence of cardiovascular diseases, availability of large number of LOC-based products for cardiac biomarkers, and relatively greater adoption of these products among end-users.
Geographically, the global microfluidic immunoassay market is categorized into – North America (U.S. and Canada), Europe (Germany, France, Italy, U.K., Spain, and RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America accounted for the largest share of the globalmicrofluidic immunoassay market, due to its remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology; increasing prevalence of chronic diseases with expanding proportion of elderly population; and presence of leading players in the market in this region.
The global microfluidic immunoassay market is consolidated with top 2 players namely Abbott Laboratories (U.S.) and Quidel Corporation (U.S.) holding major share of this market. These players are continuously focusing on organic as well as inorganic growth strategies to maintain their strong foothold in the market. The other key players in this market are Abaxis, Inc. (a subsidiary of Zoetis Inc.), Nanōmix, Inc., Abbott Laboratories, Koninklijke Philips N.V., Biosurfit SA, Micropoint Bioscience, Inc., Siloam Biosciences, NanoEnTek Inc., OPKO Health, Inc., and Quidel Corporation.
Browse key industry insights spread across 207 pages with 227 market data tables & 42 figures & charts from the report: https://www.meticulousresearch.com/product/microfluidic-immunoassay-market-5034/
Scope of the Report:
Microfluidic Immunoassay Market by Product Type
Lab-on-chip/microfluidic diagnostics
Microfluidic Analyzers
MicrofluidicCartridges
Other Quantifiable POC diagnostics
POC Analyzers
Reagents and Assays
Microfluidic Immunoassay Market by Technology
Point of Care Lab on Chip Technology
Electrochemical LOC POC Technology
Optical POC LOC Technology
Non Lab on Chip Point of Care Technology
Microfluidic Immunoassay Market by Application
Cardiac Biomarker Detection
Single Biomarker Assay
Troponin
Brain Natriuretic Peptide (BNP)
Other Cardiac Biomarkers
Multiplexed Panel Assay
Inflammatory Biomarker Detection
Other Biomarkers
Emerging Biomarkers
Microfluidic Immunoassay Market by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of Asia-Pacific (RoAPAC)
Latin America
Middle East & Africa
Get Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5034
